Second-line endocrine therapy (ET) with or without palbociclib (P) maintenance in patients (pts) with hormone receptor-positive (HR[+])/human epidermal growth factor receptor 2-negative (HER2[-]) ...

Adaptive randomization is neither ethically nor statistically preferable. Randomization requires equipoise. 2 As long as equipoise exists, there is no logical or ethical reason to favor one treatment ...

Vaccine maker , also known as the Chemo-Sero-Therapeutic Research Institute, has become the first Japanese pharmaceutical company to use the combined capabilities of the ™ randomization and trial ...

Mendelian randomization is a study design that uses genetic variants as instrumental variables to test the causal effect of a (non-genetic) risk factor on a disease or health-related outcome. Since ...